QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers ...Middle East

Results demonstrated statistically significant effects on biomarkers that predict ALS disease progression and severity Evidence of brain penetration, target engagement, and potential anti-seizure effects demonstrated through biomarkers for TMS-EMG and EEG Safety and tolerability profile...

Read More Details
Finally We wish PressBee provided you with enough information of ( QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers )

Also on site :

• Over 20 Palestinians, children included, killed in Israeli airstrikes in Gaza
• Dem Bulb: Scott Jennings Laughs that Failure of Fake Biden Town Hall Was Blamed on Bad Lighting
• Suspect search underway after woman shot on West El Camino Avenue in Natomas